FDA Approves Caris Life Sciences CDx for Targeted Cancer Therapy Precision
Caris Life Sciences’ MI Cancer Seek CDx assay received FDA approval to help identify cancer patients who may benefit from targeted therapies.
Read MorePosted by Andy Lundin | Nov 7, 2024 | Cancer |
Caris Life Sciences’ MI Cancer Seek CDx assay received FDA approval to help identify cancer patients who may benefit from targeted therapies.
Read MorePosted by Andy Lundin | Nov 7, 2024 | Diagnostic Technologies, Lung Cancer |
The system enables detection and personalized care for diseases like Cystic Fibrosis, Chronic Obstructive Pulmonary Diseases, and lung cancer.
Read MorePosted by Andy Lundin | Nov 6, 2024 | Lung Cancer |
Researchers developed a sensor that can detect low levels of isoprene in exhaled breath, potentially enabling early lung cancer diagnosis.
Read MorePosted by Chris Wolski | Oct 31, 2024 | Cancer |
Scientists at deCODE genetics/Amgen and their collaborators have identified six new genes with rare germline variants linked to cancer risk.
Read MorePosted by Chris Wolski | Oct 31, 2024 | Emerging & Zoonotic Diseases |
A new noninvasive malaria test can detect malaria-infected cells in the bloodstream without requiring a blood sample.
Read More